CMCarla Z. Minutti

Carla Z. Minutti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carla Z. Minutti has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MON-082 The Neonatal Screen That Cried Wolff

    by Fabiola D’aMbrosio, Laika M Nur, Stelios Mantis, Carla Z Minutti

    Introduction: Hypothyroidism is one of the major causes of preventable mental retardation. Neonatal screening aids in the prompt diagnosis of newborns with congenital hypothyroidism. There are other clinical conditions that can alter thyroid function during the newborn period, including exposure of high iodine concentrations. Case Presentation: One day old female born at 37 3/7 weeks of gestational age by C-section with imperforated anus and congenital heart disease was transferred to our children’s hospital within the first day of life for a hybrid cardiac procedure of bilateral pulmonary artery banding and PDA stenting. She had an Illinois Neonatal screen done at 36 hours of life that was normal. Her cardiac surgery was performed at 10 days of life, where she was exposed to iodine products transdermally. At 14 days of age, she had a repeat Illinois Neonatal screen that was positive for congenital hypothyroidism with a TSH of 78 mIu/mL (normal < 20 mIu/mL) and reflex total T4 of 5.4ug/dL (normal is > 8ug/dL). No family history of thyroid disease; mother was healthy during pregnancy and was not on medications that could affect baby’s thyroid function. Subsequent serum laboratory testing confirmed a TSH of 74.3mIu/mL and Free T4 of 0.6ng/dL. Patient was diagnosed with Wolff-Chaikoff effect, which is the phenomenon of transient hypothyroidism caused by exposure to high doses of iodine (iodine containing contrast agents or topical antiseptics). Pediatric Endocrinology was consulted at 2 weeks of life and she was started on 25mcg of levothyroxine PO daily. Levothyroxine dose decreased at 16 month of age to 12.5mcg due to stable thyroid function tests. The patient was last seen at 30 months of age by Pediatric Endocrinology. She is still on the low dose of levothyroxine and her thyroid labs have been within normal limits for an infant. She will likely not require lifelong thyroid supplementation. Conclusion: Risk of hypothyroidism among neonates must be considered seriously after large iodine exposure and monitoring for transient hypothyroidism should be performed. It is thus recommended that attempts should be made to reduce the amount of iodine used during procedures and to carefully monitor thyroid function in all neonates exposed to an excess of iodine. Reference: Markou, K., et al. “Iodine-Induced Hypothyroidism.” Thyroid, vol. 11, no. 5, 2001, pp. 501–510., doi:10.1089/105072501300176462. Linder N, Sela B, German B, et al. Iodine and hypothyroidism in neonates with congenital heart disease. Archives of Disease in Childhood - Fetal and Neonatal Edition 1997;77:F239-F240. Kovacikova, Lubica, et al. “Thyroid Function and Ioduria in Infants after Cardiac Surgery: Comparison of Patients with Primary and Delayed Sternal Closure.” Pediatric Critical Care Medicine, vol. 6, no. 2, 1 Mar. 2005, pp. 154–159., doi:10.1097/01.pcc.0000154960.59452.06.


  • Case 3: Prognathism in a 13-year-old Boy

    by Jacqueline T. Chan, Carla Z. Minutti

    Review of previous records shows crossing of height percentiles from the 75th to above the 95th from 9 to 11 years old, whereas his weight has been stable. Records before this age were not available because the patient is …

  • Inefficiency of levothyroxine suspension in a neonate with congenital hypothyroidism

    by Jacqueline T. Chan, Fabiola D’aMbrosio, Carla Z. Minutti

    Background: Congenital hypothyroidism is one of the major causes of preventable mental retardation. Diagnosis, hormonal replacement and normalization of thyroid function tests should happen before 2–3 weeks of life. Levothyroxine is the treatment of choice for congenital hypothyroidism. Case presentation: A patient born at 32 weeks for gestational age with a birthweight of 1.73 kg. The pregnancy and delivery were uncomplicated. The physical exam was unremarkable. The initial newborn screen noted a thyroid stimulating hormone (TSH) of 70.5 mIU/mL (n < 20 mIU/mL). Serum thyroid function test revealed a TSH of 215 mIU/mL and free thyroxine (FT4) of 0.08 ng/dL. The patient was started on levothyroxine 25 μg tablet daily at day of life (DOL) 7. Repeat TSH and FT4 after 1 week of treatment, revealed a TSH of 0.686 and FT4 of 4.12 ng/dL, levothyroxine was discontinued. Repeat tests after 1 week, showed a TSH of 47.5 mIU/mL and a FT4 of 0.84 ng/dL. Levothyroxine in a liquid form at 25 μg a day was started on DOL 21. On DOL 38, TSH was repeated and was noted to be 120 mIU/mL. Levothyroxine was switched to a tablet formulation and was increased to 37.5 μg daily. Repeat tests at DOL 50, showed a TSH that was trending down to 9.241 mIU/mL. Conclusion: Levothyroxine (T4) is a synthetic hormone considered to be the standard of care for the treatment of congenital hypothyroidism. Treatment is most effective if given orally in tablet form. To date, there are no liquid formulations and no compounding recipes that produce a stable concentration of levothyroxine in the USA. Efforts to create suspensions, especially for neonates, should be carefully considered as this is a critical time for brain development. The case presented shows how treatment of congenital hypothyroidism can be ineffective if using a liquid formulation of levothyroxine.


  • Open Access

    Serum Thyroid-Stimulating Hormone Levels and Body Mass Index Percentiles in Children with Primary Hypothyroidism on Levothyroxine Replacement

    by Asma Shaoba, Sanjib Basu, Stelios Mantis, Carla Minutti

    To determine if there is a association between TSH levels and BMI percentiles in children with primary hypothyroidism who are chemically euthyroid and on treatment with levothyroxine.Retrospective cross-sectional study, consisting of review of medical records from RUSH Medical Center and Stroger Hospital, Chicago, IL, U.SA. Children (seen in clinic from 2008-2014) with primary hypothyroidism who were chemically euthyroid and on treatment with levothyroxine for at least 6 months were included in the study. Patients were divided into 2 groups based on their TSH levels. (TSH ranges 0.34-<2.5 mIU/L and ≥2.5-5.6 mIU/L). Data was analyzed by Spearman rank correlation, linear regression, Cross Tabulation & Chi-Square, Mann-Whitney U test and Kruskal-Wallis test.146 children were included, of which 26% were obese (BMI ≥95%), 21.9% were overweight (BMI ≥85-<95%), and 52.1% had a healthy weight (BMI <85%). There was a significant positive correlation between TSH and BMI percentiles (r = 0.274, P = 0.001) and a significant negative correlation between TSH and serum free T4 (r =-0.259, P = 0.002). In the lower TSH group, 68.4% of the children had a healthy weight, while the percentage of obese children was 60.5% in the upper TSH group (P = 0.012).In children diagnosed with primary hypothyroidism who are chemically euthyroid on treatment with levothyroxine, there is a positive association between higher TSH levels and higher BMI percentiles. However, it is difficult to establish if the higher TSH levels are a direct cause or a consequence of the obesity. Further studies are needed to establish causation beyond significant association.


  • Open Access

    Warts of the Fingertips in a Pediatric Patient With Type 1 Diabetes

    by Jacqueline T. Chan, Teresa Alesia, Carla Z. Minutti

    An 11-year-old girl, diagnosed with type 1 diabetes 3 years ago, presented to the pediatric endocrinology clinic for her scheduled, quarterly follow-up visit. She and her mother received diabetes self-management instruction from a certified diabetes educator at the time of diagnosis and received ongoing self-management education at her regular visits. Her glucose control was suboptimal, with an A1C of 11.4% (normal <6.5%). The patient was largely responsible for her own diabetes care because her mother is a single parent and works full-time. During the visit, the patient’s mother mentioned that, in the past few months, the child had developed lesions on her fingertips. These lesions were appearing at the sites where she uses a lancet to prick her fingers for capillary blood glucose monitoring several times per day. The patient assured the diabetes care team that she used alcohol swabs to clean the …


  • Implementation of a Diabetes Transition of Care Program

    by Jeanne M. Little, Janice A. Odiaga, Carla Z. Minutti


  • Measurement of Salivary Cortisol Level for the Diagnosis of Critical Illness–Related Corticosteroid Insufficiency in Children*

    by Vishal Gunnala, Rong Guo, Carla Minutti, Ramon Durazo-Arvizu, Cynthia Laporte, Herbert Mathews, Stephanie Kliethermis, Rahul Bhatia

    To compare serum total, serum free and salivary cortisol in critically ill children. Prospective observational cohort study. Tertiary pediatric critical care unit at Ronald McDonald Children's Hospital at Loyola University Medical Center. We enrolled 59 patients (4 weeks to 18 years of age) between January 2012 and May 2013. Thirty-four patients were included in the salivary to serum free cortisol correlational analysis. Blood and saliva samples were obtained simultaneously within 24 hours of admission between the hours of 6 AM and 12 PM. Salivary cortisol was tested by liquid chromatography/tandem mass spectrometry, serum free cortisol by liquid chromatography/tandem mass spectrometry followed by equilibrium dialysis, and serum total cortisol by liquid chromatography/tandem mass spectrometry. Salivary and serum free cortisol values from 34 patients had a correlation coefficient (r) of 0.87 (95% CI, 0.75-0.93; p < 0.0001). The total serum and salivary cortisol values had a correlation coefficient (r) of 0.67 (95% CI, 0.42-0.81; p < 0.0001). The total serum and serum free cortisol values had a correlation coefficient (r) of 0.83 (95% CI, 0.69-0.91; p < 0.0001). Serum free and salivary cortisol values correlate in critically ill children. Salivary cortisol can be used as a surrogate for serum free cortisol in critically ill pediatric patients. Salivary cortisol is a cost-effective and less invasive measure of bioavailable cortisol and offers an alternate and accurate method for assessing critical illness-related corticosteroid insufficiency in children.


  • Prevalence of risk of deficiency and inadequacy of 25-hydroxyvitamin D in US children: NHANES 2003–2006

    by Vytas P. Karalius, Daniel Zinn, James Wu, Guichan Cao, Carla Minutti, Amy Luke, Holly Kramer, Ramon Durazo-Arvizu

    Aim: To assess prevalence and population estimates of increased risk of 25-hydroxyvitamin D [25(OH)D] deficiency and inadequacy in US children based on the current Institute of Medicine Committee to Review Dietary References Intakes for Vitamin D and Calcium guidelines. Methods: The analysis was limited to a nationally representative sample of non-institutionalized US children and adolescents aged 6–18 years who participated in the National Health and Nutrition Examination Survey completed in 2003–2006 and had complete data on 25(OH)D measurements (n=2877). The 25(OH)D levels were adjusted for assay drift and prevalence, and population estimates of increased risk of 25(OH)D deficiency (Results: Overall, 4.61% of children and adolescents are at increased risk of deficiency (population estimate 2.5 million) and 10.3% are at risk of inadequacy (population estimate 5.5 million) based on the Institute of Medicine guidelines. Conclusion: Approximately 10.3% of US children aged 6–18 years (population estimate 5.5 million) have 25(OH)D levels <16 ng/mL.


  • Aspergillus thyroiditis: a review of the literature to highlight clinical challenges

    by J. Nguyen, R. Manera, C. Minutti

    Aspergillus involvement of the thyroid is the most commonly reported fungal thyroiditis. Aspergillus thyroiditis (AT) has primarily been a postmortem diagnosis in immunocompromised patients with diagnosed disseminated invasive Aspergillus or high suspicion of fungal infection during life. With better treatment modalities for the comorbidities that place patients at high risk for fungal infections, as well as better antifungal therapies for Aspergillus infections specifically, the spectrum of disease and presentation of AT may be shifting from what was primarily a postmortem finding to an antemortem diagnosis, necessitating a high index of clinical suspicion and timely intervention. We present a review of the literature to better clarify clinical features, diagnostic modalities, and management considerations pertaining to this disease.


  • Steroid Profiling by Tandem Mass Spectrometry Improves the Positive Predictive Value of Newborn Screening for Congenital Adrenal Hyperplasia

    by Carla Z. Minutti, Jean M. Lacey, Mark J. Magera, Si Houn Hahn, Mark McCann, Andreas Schulze, David Cheillan, Claude Dorche, Donald H. Chace, James F. Lymp, et al.

    Congenital adrenal hyperplasia (CAH) is primarily caused by 21-hydroxylase deficiency and leads to an accumulation of 17-hydroxyprogesterone and reduced cortisol levels. Newborn screening for CAH is traditionally based on measuring 17-hydroxyprogesterone by different immunoassays. Despite attempts to adjust cutoff levels for birth weight, gestational age, and stress factors, the positive predictive value for CAH screening remains less than 1%. To improve this situation, we developed a method using liquid chromatography-tandem mass spectrometry to measure 17-hydroxyprogesterone, androstenedione, and cortisol simultaneously in blood spots. A total of 1222 leftover blood spots from six different screening programs using different immunoassays (fluorescent immunoassay and ELISA) were reanalyzed in a blinded fashion by liquid chromatography-tandem mass spectrometry. Thirty-one samples were from babies with CAH, 190 had yielded false-positive results by immunoassay, and the remaining 1001 samples were from babies with normal screening results. Steroid profiling allowed for an elimination of 169 (89%) of the false-positive results and for an improvement of the positive predictive value from the reported 0.5 to 4.7%. Although this method is not suitable for mass screening due to the length of the analysis (12 min), it can be used as a second-tier test of blood spots with positive results for CAH by the conventional methods. This would prevent unnecessary blood draws, medical evaluations, and stress to families.